Cerebrolysin · For age-related cognitive decline

Cerebrolysin for age-related cognitive decline

You're 60+, slowing down mentally. Cerebrolysin off-label?

A-Tier Cognitive Strong clinical

New to peptides? Start with the foundations ->

Why people use Cerebrolysin for age-related cognitive decline

You're 60+, slowing down mentally. Cerebrolysin off-label? The short answer: yes, this is one of the more-discussed uses for Cerebrolysin - but the evidence quality and the right protocol depend on what you're actually trying to fix.

This page covers what's known, what's not, and what the editorial take is for normal humans considering Cerebrolysin for age-related cognitive decline.

What the evidence says

Evidence tier: Strong clinical. Multiple human studies support the dosing protocol; not yet FDA-labeled for this exact indication but close.

Mild cognitive impairment trials showed modest improvement in memory scores.
Often used preventively in countries where it is approved.
Off-label US use exists through longevity clinics; sourcing is the choke point.

Protocol notes

10-15mL IV or IM (intramuscular) infusion daily for 10 days, every 6 months. Longevity or anti-aging clinic.

Always with a sports-medicine doctor, telehealth provider, or specialist sign-off. Self-experimenting on injection schedules without clinical input is the most common way people waste money and get hurt.

How it's dosed (quick version)

Standard protocol is 10 to 30 milliliters (a small IV push or slow infusion) daily for 10 to 21 days, repeated every 3 to 6 months. Sourcing in the US is the real challenge - it is not FDA-approved here. Always with a doctor, ideally a neurologist or longevity-clinic prescriber.

Typical starting dose: 5 to 10 mL IV (intravenous, into a vein) on day 1 to test tolerance, then escalate to the full protocol dose.
Typical maintenance dose: 10 to 30 mL IV daily during the 10 to 21-day cycle. Stroke and TBI protocols use the higher end (20-30 mL); longevity protocols stay at 10-15 mL.
Frequency: Daily during the active cycle. Cycle repeated every 3 to 6 months.
Cycle length: 10 to 21 days of daily infusion. Stroke acute care often runs 21 days; maintenance protocols run 10 days.

Full dosing breakdown ->

What to skip

Vendors without a Certificate of Analysis (COA). Random gym-bro vendors with no third-party testing. The peptide market has a quality-control problem; the answer is COA per peptide, every time.
Pre-mixed blends from non-pharmacy sources. Compounding pharmacies that produce pre-mixed combinations with COAs are fine. Random vendor "stack vials" are not.
Massively over-dosed protocols. More is rarely better with peptides. Receptor saturation is real. Stick to evidence-based dosing.

Where to go next

Full Cerebrolysin directory entry - status, sourcing, studies, what to skip
What are peptides - if you skipped the foundation
How peptides actually work - mechanism in plain English
The Tier List - which ones to take seriously
Subscribe to the dispatch

Subscribe to the dispatch

The weekly Protocol One dispatch covers what's moving in peptides, GLP-1s, and longevity protocols. Free. 5-min read. Broken down for normal humans.

-> Subscribe free

Last reviewed · 2026-05-07 · Page generated by Protocol One matrix engine